Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_assertion description "[Thus, our findings for the first time indicate that targeting XIAP represents a promising strategy to enhance the antitumor activity of TRAIL in pancreatic cancer, which has important clinical implications.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_assertion evidence source_evidence_literature NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_assertion SIO_000772 16832350 NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_assertion wasDerivedFrom befree-20150227 NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_assertion wasGeneratedBy ECO_0000203 NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP242531.RAbCHxLnrb_WIuNsOW3gf-zW317T1m6-lFNg5cG26BzK4130_provenance.